A Drug Discovery Approach for an Effective Pain Therapy through Selective Inhibition of Nav1.7
Chronic pain is a widespread disorder affecting millions of people and is insufficiently addressed by current classes of analgesics due to significant long-term or high dosage side effects. A promising approach that was recently proposed involves the systemic inhibition of the voltage-gated sodium c...
Main Authors: | Gabriele A. Trombetti, Alessandra Mezzelani, Alessandro Orro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/12/6793 |
Similar Items
-
Historical Perspective of the Characterization of Conotoxins Targeting Voltage-Gated Sodium Channels
by: James R. Groome
Published: (2023-03-01) -
Electrophysiological characterization of schizophrenia-associated variants in NaV1.2 sodium channel
by: M. Suslova, et al.
Published: (2022-06-01) -
Optical measurement of gating pore currents in hypokalemic periodic paralysis model cells
by: Tomoya Kubota, et al.
Published: (2023-06-01) -
Expert Consensus on Ion Channel Drugs for Chronic Pain Treatment in China
by: Ma K, et al.
Published: (2024-03-01) -
Unveiling Targets for Treating Postoperative Pain: The Role of the TNF-α/p38 MAPK/NF-κB/Nav1.8 and Nav1.9 Pathways in the Mouse Model of Incisional Pain
by: Flávia Oliveira de Lima, et al.
Published: (2022-10-01)